---
document_datetime: 2024-06-05 14:45:41
document_pages: 14
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/pecfent-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: pecfent-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 8.4758586
conversion_datetime: 2025-12-30 01:50:56.878289
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## PecFent

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                |
|----------------------|-----------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------|
| T/0061               | Transfer of Marketing Authorisation                                                           | 19/04/2024                          | 16/05/2024                                  | SmPC, Labelling and PL           |                                                                                                                        |
| PSUSA/1369/ 202304   | Periodic Safety Update EU Single assessment - fentanyl (transmucosal route of administration) | 25/01/2024                          | 25/03/2024                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                |            |            |                        | PSUSA/1369/202304.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------|
| IA/0058   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                           | 03/05/2023 | n/a        |                        |                      |
| IB/0057   | B.II.e.1.a.2 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms                                                                                                                                       | 17/04/2023 | n/a        |                        |                      |
| II/0054   | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required                 | 29/09/2022 | 23/08/2023 | Annex II               |                      |
| IB/0056   | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                 | 21/04/2022 | 15/07/2022 | SmPC, Labelling and PL |                      |
| IB/0055   | C.I.1.b - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a Union referral procedure - The product is not covered by the defined scope of the procedure but the change(s) implements the outcome of the procedure and no new additional data is required to be submitted by the MAH | 25/02/2022 | 15/07/2022 | Labelling              |                      |
| IB/0053/G | This was an application for a group of variations.                                                                                                                                                                                                                                                             | 22/07/2021 | 15/07/2022 | SmPC,                  |                      |

<div style=\"page-break-after: always\"></div>

|                    | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation   |            |            | Labelling and PL   |                                                                                                                                           |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/1369/ 202004 | Periodic Safety Update EU Single assessment - fentanyl (transmucosal route of administration)                                                                                                                                                                                                                                                                                                   | 28/01/2021 | 31/03/2021 | SmPC and PL        | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1369/202004. |
| IB/0052            | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                                    | 04/11/2020 | n/a        |                    |                                                                                                                                           |
| IB/0050            | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                     | 12/06/2020 | n/a        |                    |                                                                                                                                           |
| IB/0049            | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                                                                                  | 25/06/2019 | 18/06/2020 | SmPC and PL        |                                                                                                                                           |
| N/0048             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                | 25/01/2019 | 18/06/2020 | Labelling and PL   |                                                                                                                                           |
| IAIN/0047/G        | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                | 27/09/2018 | n/a        |                    |                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|                    | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                                                                                                                                                                                                                                                                                 |            |            |                        |                                                                                                                                           |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| T/0046             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 02/07/2018 | 19/07/2018 | SmPC, Labelling and PL |                                                                                                                                           |
| PSUSA/1369/ 201704 | Periodic Safety Update EU Single assessment - fentanyl (transmucosal route of administration)                                                                                                                                                                                                                                                                                                                                                                                                       | 22/02/2018 | 08/05/2018 | SmPC and PL            | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1369/201704. |
| IAIN/0045          | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                          | 18/01/2018 | 08/05/2018 | SmPC, Labelling and PL |                                                                                                                                           |
| IA/0041/G          | This was an application for a group of variations. B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an alternative method is already authorised | 27/04/2017 | n/a        |                        |                                                                                                                                           |
| N/0042             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                    | 25/04/2017 | 02/06/2017 | Labelling and PL       |                                                                                                                                           |
| N/0040             | Minor change in labelling or package leaflet not                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 24/11/2016 | 02/06/2017 | PL                     |                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|           | with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                     | connected                    |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------|------------------------------|
| N/0039    | Update to Section 4 of the package leaflet to add side effects in line with those already listed in the SmPC. In addition, the MAH has updated the package leaflet with revised contact details of the local representatives for Belgium, Bulgaria, Denmark, Germany, Finland, France, the Netherlands, Norway and Sweden. Minor change in labelling or package leaflet not 61.3 Notification)                                                                                                                                                                                                                          | 15/08/2016 | 02/06/2017 | PL                  | connected with the SPC (Art. |
| IA/0038/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 28/06/2016 | n/a        |                     |                              |
| IB/0037/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 16/06/2016 | 02/06/2017 | SmPC, Labelling and |                              |

<div style=\"page-break-after: always\"></div>

|           | in pack size of the finished product - Change in the fill weight/fill volume of nonparenteral multi-dose (or single-dose, partial use) products B.II.e.6.a - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that affects the product information B.II.e.6.a - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that affects the product information B.II.e.6.z - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Other variation B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation   |            |            | PL   | B.II.e.5.d - Change   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------|
| IAIN/0036 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 09/12/2015 | n/a        |      |                       |
| N/0035    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 16/11/2015 | 02/06/2017 | PL   |                       |
| IAIN/0034 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 24/09/2015 | n/a        |      |                       |

<div style=\"page-break-after: always\"></div>

| R/0032             | Renewal of the marketing authorisation.                                                                                                                                                                                                                                | 21/05/2015   | 17/07/2015   | SmPC, Labelling and PL   | Based on the review of data on quality, safety and efficacy, including all variations introduced since the marketing authorisation was granted, the CHMP considered that the benefit-risk balance of Pecfent in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity.   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0033          | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                        | 20/05/2015   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                            |
| PSUSA/1369/ 201404 | Periodic Safety Update EU Single assessment - fentanyl (transmucosal route of administration)                                                                                                                                                                          | 18/12/2014   | 30/03/2015   | SmPC and PL              | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1369/201404.                                                                                                                                                                                                                  |
| II/0031            | Submission of the final Study report for the PecFent French Drug Utilisation Study (DUS) CP064/1 dated 1st October 2014. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority | 26/03/2015   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                            |
| IAIN/0030          | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                | 09/10/2014   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                            |
| IB/0029            | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                          | 04/09/2014   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

| IB/0027            | To add adverse event reporting details to section 4.8 of the SmPC and section 4 of the PL following the QRD template version 9. In addition, minor text errors and minor grammatical errors were amended. Finally the contact details of the local representative for Croatia were updated. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation   | 02/06/2014   | 30/03/2015   | SmPC, Annex II, Labelling and PL   |                                                                                                                                        |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/1369/ 201304 | Periodic Safety Update EU Single assessment - fentanyl (transmucosal route of administration)                                                                                                                                                                                                                                                                                                | 19/12/2013   | 28/02/2014   | SmPC and PL                        | Refer to the Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation for PSUSA/1369. |
| IB/0026            | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                       | 08/01/2014   | n/a          |                                    |                                                                                                                                        |
| IA/0025            | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                        | 22/11/2013   | n/a          |                                    |                                                                                                                                        |
| IB/0024            | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                         | 21/11/2013   | n/a          |                                    |                                                                                                                                        |
| IA/0022            | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph                                                                                                                                                                                                                                    | 31/10/2013   | n/a          |                                    |                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

|           | the Ph. Eur. or national pharmacopoeia of a State                                                                                                                                                                                                                                                                                                                                        |            |     | of Member      |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------|
| IA/0020   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                                                                                                                       | 16/10/2013 | n/a | procedure      |
| IA/0021   | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                           | 11/10/2013 | n/a |                |
|           | This was an application for a group of variations. B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging | 03/10/2013 | n/a | IB/0018/G site |
| IAIN/0017 | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                                                                                                                                                                      | 13/09/2013 | n/a |                |
| IA/0016/G | This was an application for a group of variations. B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement                                                                                                                                                                                                                                 | 11/01/2013 | n/a |                |

<div style=\"page-break-after: always\"></div>

|          | or addition of a site where batch control/testing takes place B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                  |            |            |                        |                                                                                                                                      |
|----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------|
| IB/0014  | B.II.f.1.b.2 - Stability of FP - Extension of the shelf life of the finished product - After first opening (supported by real time data)                                                                                                                                                                                                                                                                                                                                                    | 25/10/2012 | 31/10/2012 | SmPC, Labelling and PL |                                                                                                                                      |
| A20/0013 | Pursuant to Article 20 of Regulation (EC) No 726/2004, the European Commission requested the opinion of the CHMP further to the concerns raised during a Good Clinical Practice inspection on the conduct of bio-analytical studies by the Cetero Research facilities (Houston, USA), to assess the impact thereof on the risk-benefit balance of PecFent and to give its opinion whether the marketing authorisation of this product should be maintained, varied, suspended or withdrawn. | 19/07/2012 | 24/09/2012 |                        | Please refer to the assessment report : EMEA/H/C/1164/A- 20/0013                                                                     |
| IB/0012  | B.II.e.1.a.2 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms                                                                                                                                                                                                                                                                                                                    | 29/06/2012 | n/a        |                        |                                                                                                                                      |
| N/0011   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                            | 08/06/2012 | 24/09/2012 | Labelling              | The Marketing Authorisation Holder (MAH) took the opportunity to update Annex IIIA following feedback from healthcare professionals. |

<div style=\"page-break-after: always\"></div>

| II/0008     | to widen the release specification for the excipient propylparahydroxybenzoate. B.II.c.1.d - Change in the specification parameters and/or limits of an excipient - Change outside the approved specifications limits range                                                                                                                                                                                                                                                                           | 24/05/2012   | 24/05/2012   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|
| IAIN/0010   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                    | 24/04/2012   | n/a          |
| IA/0009     | C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                                                                                                                                                                                                                | 17/02/2012   | n/a          |
| IB/0006/G   | This was an application for a group of variations. B.II.e.1.b.1 - Change in immediate packaging of the finished product - Type of container - Solid, semi- solid and non-sterile liquid pharmaceutical forms B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products | 01/02/2012   | n/a          |
| IAIN/0007/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the                                                                                                                                                                                                                                                                                                                                                 | 10/01/2012   | n/a          |

<div style=\"page-break-after: always\"></div>

|         | QPPV C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.d - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the safety database C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.g - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the site undertaking pharmacovigilance activities C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of   |            |            |             |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| II/0005 | to change the description of the features of the bottle after the end of normal use and change the precautions for disposal in sections 4.2, 6.5 and 6.6 of the SmPC and sections 3, 5 and 6 of Patient Leaflet. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre-                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 20/10/2011 | 22/11/2011 | SmPC and PL |

<div style=\"page-break-after: always\"></div>

|           | clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |     |          |                              |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|------------------------------|
| IA/0004/G | This was an application for a group of variations. C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.d - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the safety database C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of | 03/05/2011 | n/a | Annex II | the pharmacovigilance system |
| N/0003    | The Marketing Authorisation Holder (MAH) took the opportunity to update details of the local representatives in Annex IIIB. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 16/12/2010 | n/a | PL       |                              |
| IB/0002   | To extend the shelf-life of the finished product from 24 to 36 months. of FP - Extension of the shelf                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 29/11/2010 | n/a | SmPC     | B.II.f.1.b.1 - Stability     |

<div style=\"page-break-after: always\"></div>

|           | of the finished product - As packaged for sale by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |                        | life (supported            |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------|
| IB/0001/G | This was an application for a group of variations. To add a new pack size of 12 bottles for the 100 and 400 g strengths (EU/1/10/644/005-006). B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside approved pack sizes | 29/11/2010 | 29/11/2010 | SmPC, Labelling and PL | the range of the currently |